Altium Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-57,271
| Closed | -$2.48M | – | 78 |
|
|
2024
Q1 | $2.48M | Buy |
57,271
+50,786
| +783% | +$2.2M | 0.98% | 29 |
|
|
2023
Q4 | $298K | Buy |
+6,485
| New | +$298K | 0.2% | 35 |
|
|
2023
Q1 | – | Sell |
-170,000
| Closed | -$4.95M | – | 104 |
|
|
2022
Q4 | $4.95M | Hold |
170,000
| – | – | 2.52% | 11 |
|
|
2022
Q3 | $4.17M | Buy |
+170,000
| New | +$4.17M | 1.53% | 17 |
|
|
2021
Q3 | – | Sell |
-104,840
| Closed | -$2.05M | – | 150 |
|
|
2021
Q2 | $2.05M | Sell |
104,840
-118,160
| -53% | -$2.31M | 0.48% | 81 |
|
|
2021
Q1 | $4.74M | Buy |
+223,000
| New | +$4.74M | 1.32% | 25 |
|